DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE tablet United States - English - NLM (National Library of Medicine)

diphenoxylate hydrochloride and atropine sulfate tablet

physicians total care, inc. - diphenoxylate hydrochloride (unii: w24od7yw48) (diphenoxylate - unii:73312p173g), atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i) - diphenoxylate hydrochloride 2.5 mg - diphenoxylate hydrochloride and atropine sulfate tablets are effective as adjunctive therapy in the management of diarrhea. diphenoxylate hydrochloride and atropine sulfate tablets are contraindicated in patients with - known hypersensitivity to diphenoxylate or atropine, - obstructive jaundice, - diarrhea associated with pseudomembranous enterocolitis or enterotoxin-producing bacteria. diphenoxylate hydrochloride and atropine sulfate tablets are classified as a schedule v controlled substance. diphenoxylate hydrochloride is chemically related to the narcotic analgesic meperidine. in doses used for the treatment of diarrhea, whether acute or chronic, diphenoxylate has not produced addiction. diphenoxylate hydrochloride is devoid of morphine-like subjective effects at therapeutic doses. at high doses it exhibits codeine-like subjective effects. the dose which produces antidiarrheal action is widely separated from the dose which causes central nervous system effects. the insolubility of diphenoxylate

LORAZEPAM- lorazepam tablet United States - English - NLM (National Library of Medicine)

lorazepam- lorazepam tablet

mckesson corporation dba sky packaging - lorazepam (unii: o26fzp769l) (lorazepam - unii:o26fzp769l) - lorazepam 0.5 mg - lorazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the effectiveness of lorazepam in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. the physician should periodically reassess the usefulness of the drug for the individual patient. lorazepam is contraindicated in patients with

SERTRALINE tablet, film coated United States - English - NLM (National Library of Medicine)

sertraline tablet, film coated

heritage pharmaceuticals inc. d/b/a avet pharmaceuticals inc. - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - sertraline hydrochloride tablets are indicated for the treatment of the following [see clinical studies (14) ]: • major depressive disorder (mdd) • obsessive-compulsive disorder (ocd) • panic disorder (pd) • posttraumatic stress disorder (ptsd) • social anxiety disorder (sad) • premenstrual dysphoric disorder (pmdd) sertraline hydrochloride tablets are contraindicated in patients: - taking, or within 14 days of stopping, maois, (including the maois linezolid and intravenous methylene blue) because of an increased risk of serotonin syndrome [see warnings and precautions (5.2), drug interactions (7.1) ]. - taking pimozide [see drug interactions (7.1) ]. - with known hypersensitivity to sertraline (e.g., anaphylaxis, angioedema) [see adverse reactions (6.1, 6.2) ]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants during pregnancy. healthcare providers should encourage patients to enroll by calling the national pregnancy

FENOFIBRATE- fenofibrate tablet, coated United States - English - NLM (National Library of Medicine)

fenofibrate- fenofibrate tablet, coated

nucare pharmaceuticals,inc. - fenofibrate (unii: u202363uos) (fenofibric acid - unii:bgf9mn2hu1) - fenofibrate 48 mg - fenofibrate tablets usp are indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol (ldl-c), total cholesterol (total-c), triglycerides and apolipoprotein b (apo b), and to increase high-density lipoprotein cholesterol (hdl-c) in adult patients with primary hypercholesterolemia or mixed dyslipidemia. fenofibrate tablets usp are also indicated as adjunctive therapy to diet for treatment of adult patients with severe hypertriglyceridemia. improving glycemic control in diabetic patients showing fasting chylomicronemia will usually obviate the need for pharmacologic intervention. markedly elevated levels of serum triglycerides (e.g., > 2,000 mg/dl) may increase the risk of developing pancreatitis. the effect of fenofibrate therapy on reducing this risk has not been adequately studied. fenofibrate at a dose equivalent to 145 mg of fenofibrate tablets usp was not shown to reduce coronary heart disease morbidity and mortality in a large, randomized controlled trial of pati

Dialysis Pack - Dialysis start/stop set Australia - English - Department of Health (Therapeutic Goods Administration)

dialysis pack - dialysis start/stop set

itl australia pty ltd - 32142 - dialysis start/stop set - a pre-packed set consisting of the necessary single-use instruments and items required for the start and stop procedures required to be carried out with the patient in order to perform dialysis. the procedure pack provides a selection of items, including pre-filled syringes, for the commencement and completion of haemodialysis.

Alphine Biomed Aps Keypoint Portable System Singapore - English - HSA (Health Sciences Authority)

alphine biomed aps keypoint portable system

danmedik (s) private limited - neurology - the device is intended as an electro-physiological aid to assess diagnosis and prognosis and to monitor diseases of the central and peripheral nervous system. it can also be used to study functional aspects of nerves and muscles in other fields such as rehabilitation(physical medicine), occupational medicine and sports medicine.

Alphine Biomed Aps Keypoint System Singapore - English - HSA (Health Sciences Authority)

alphine biomed aps keypoint system

danmedik (s) private limited - neurology - the device is intended as an electro-physiological aid to assess diagnosis and prognosis and to monitor diseases of the central and peripheral nervous system. it can also be used to study functional aspects of nerves and muscles in other fields such as rehabilitation(physical medicine), occupational medicine and sports medicine.

BREAS Medical Vivo 30 Ventilator Singapore - English - HSA (Health Sciences Authority)

breas medical vivo 30 ventilator

somnotec (s) pte. ltd. - general hospital - vivo 30 is intended for used by patients with spontaneous breathing and also for patients who require long term support by mechanical ventilation during the night and part of the day.

Breas Vivo 40 Ventilator Singapore - English - HSA (Health Sciences Authority)

breas vivo 40 ventilator

somnotec (s) pte. ltd. - anaesthesiology - intended for spontaneuos breathing patients who require long term support by mechanical ventilation during night and part of the day.

Natus  Keypoint G4 System Singapore - English - HSA (Health Sciences Authority)

natus keypoint g4 system

danmedik (s) private limited - neurology - the device is intended as an electro-physiological aid to assess diagnosis and prognosis and to monitor diseases of the central and peripheral nervous system. it can also be used to study functional aspects of nerves and muscles in other fields such as rehabilitation(physical medicine), occupational medicine and sports medicine.